Selected research
Industry Research
Biobased Pharmaceutical Packaging Industry Research Report 2026
Market perspective
The global Biobased Pharmaceutical Packaging market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Biobased Pharmaceutical Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Biobased Pharmaceutical Packaging is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Biobased Pharmaceutical Packaging is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Biobased Pharmaceutical Packaging include Sanner Gmbh, Gualapack, CurTec, Pont Packaging and Bormioli Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Biobased Pharmaceutical Packaging market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biobased Pharmaceutical Packaging Market by Company
Sanner Gmbh
Gualapack
CurTec
Pont Packaging
Bormioli Pharma
Biobased Pharmaceutical Packaging Segment by Type
Bottles
Bags
Caps
Others
Biobased Pharmaceutical Packaging Segment by Application
Oral Medicine
Injectable Drugs
Others
Biobased Pharmaceutical Packaging Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biobased Pharmaceutical Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biobased Pharmaceutical Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biobased Pharmaceutical Packaging.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Biobased Pharmaceutical Packaging manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Biobased Pharmaceutical Packaging by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Biobased Pharmaceutical Packaging in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Bottles
- Bags
- Caps
- Others
Applications
- Oral Medicine
- Injectable Drugs
- Others
Companies covered
- Sanner Gmbh
- Gualapack
- CurTec
- Pont Packaging
- Bormioli Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Biobased Pharmaceutical Packaging Market Size (2021-2032)
- 2.2.2 Global Biobased Pharmaceutical Packaging Sales (2021-2032)
- 2.2.3 Global Biobased Pharmaceutical Packaging Market Average Price (2021-2032)
- 2.3 Biobased Pharmaceutical Packaging by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Bottles
- 2.3.3 Bags
- 2.3.4 Caps
- 2.3.5 Others
- 2.4 Biobased Pharmaceutical Packaging by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Oral Medicine
- 2.4.3 Injectable Drugs
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Biobased Pharmaceutical Packaging Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Biobased Pharmaceutical Packaging Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Biobased Pharmaceutical Packaging Revenue of Manufacturers (2021-2026)
- 3.4 Global Biobased Pharmaceutical Packaging Average Price by Manufacturers (2021-2026)
- 3.5 Global Biobased Pharmaceutical Packaging Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Biobased Pharmaceutical Packaging, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Biobased Pharmaceutical Packaging, Product Type & Application
- 3.8 Global Manufacturers of Biobased Pharmaceutical Packaging, Established Date
- 3.9 Global Biobased Pharmaceutical Packaging Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sanner Gmbh
- 4.1.1 Sanner Gmbh Company Information
- 4.1.2 Sanner Gmbh Business Overview
- 4.1.3 Sanner Gmbh Biobased Pharmaceutical Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sanner Gmbh Biobased Pharmaceutical Packaging Product Portfolio
- 4.1.5 Sanner Gmbh Recent Developments
- 4.2 Gualapack
- 4.2.1 Gualapack Company Information
- 4.2.2 Gualapack Business Overview
- 4.2.3 Gualapack Biobased Pharmaceutical Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Gualapack Biobased Pharmaceutical Packaging Product Portfolio
- 4.2.5 Gualapack Recent Developments
- 4.3 CurTec
- 4.3.1 CurTec Company Information
- 4.3.2 CurTec Business Overview
- 4.3.3 CurTec Biobased Pharmaceutical Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 CurTec Biobased Pharmaceutical Packaging Product Portfolio
- 4.3.5 CurTec Recent Developments
- 4.4 Pont Packaging
- 4.4.1 Pont Packaging Company Information
- 4.4.2 Pont Packaging Business Overview
- 4.4.3 Pont Packaging Biobased Pharmaceutical Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pont Packaging Biobased Pharmaceutical Packaging Product Portfolio
- 4.4.5 Pont Packaging Recent Developments
- 4.5 Bormioli Pharma
- 4.5.1 Bormioli Pharma Company Information
- 4.5.2 Bormioli Pharma Business Overview
- 4.5.3 Bormioli Pharma Biobased Pharmaceutical Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Bormioli Pharma Biobased Pharmaceutical Packaging Product Portfolio
- 4.5.5 Bormioli Pharma Recent Developments
5 Global Biobased Pharmaceutical Packaging Market Scenario by Region
- 5.1 Global Biobased Pharmaceutical Packaging Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Biobased Pharmaceutical Packaging Sales by Region: 2021-2032
- 5.2.1 Global Biobased Pharmaceutical Packaging Sales by Region: 2021-2026
- 5.2.2 Global Biobased Pharmaceutical Packaging Sales by Region: 2027-2032
- 5.3 Global Biobased Pharmaceutical Packaging Revenue by Region: 2021-2032
- 5.3.1 Global Biobased Pharmaceutical Packaging Revenue by Region: 2021-2026
- 5.3.2 Global Biobased Pharmaceutical Packaging Revenue by Region: 2027-2032
- 5.4 North America Biobased Pharmaceutical Packaging Market Facts & Figures by Country
- 5.4.1 North America Biobased Pharmaceutical Packaging Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Biobased Pharmaceutical Packaging Sales by Country (2021-2032)
- 5.4.3 North America Biobased Pharmaceutical Packaging Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Biobased Pharmaceutical Packaging Market Facts & Figures by Country
- 5.5.1 Europe Biobased Pharmaceutical Packaging Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Biobased Pharmaceutical Packaging Sales by Country (2021-2032)
- 5.5.3 Europe Biobased Pharmaceutical Packaging Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Biobased Pharmaceutical Packaging Market Facts & Figures by Country
- 5.6.1 Asia Pacific Biobased Pharmaceutical Packaging Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Biobased Pharmaceutical Packaging Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Biobased Pharmaceutical Packaging Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Biobased Pharmaceutical Packaging Market Facts & Figures by Country
- 5.7.1 South America Biobased Pharmaceutical Packaging Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Biobased Pharmaceutical Packaging Sales by Country (2021-2032)
- 5.7.3 South America Biobased Pharmaceutical Packaging Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Biobased Pharmaceutical Packaging Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Biobased Pharmaceutical Packaging Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Biobased Pharmaceutical Packaging Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Biobased Pharmaceutical Packaging Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Biobased Pharmaceutical Packaging Sales by Type (2021-2032)
- 6.1.1 Global Biobased Pharmaceutical Packaging Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Biobased Pharmaceutical Packaging Sales Market Share by Type (2021-2032)
- 6.2 Global Biobased Pharmaceutical Packaging Revenue by Type (2021-2032)
- 6.2.1 Global Biobased Pharmaceutical Packaging Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Biobased Pharmaceutical Packaging Revenue Market Share by Type (2021-2032)
- 6.3 Global Biobased Pharmaceutical Packaging Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Biobased Pharmaceutical Packaging Sales by Application (2021-2032)
- 7.1.1 Global Biobased Pharmaceutical Packaging Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Biobased Pharmaceutical Packaging Sales Market Share by Application (2021-2032)
- 7.2 Global Biobased Pharmaceutical Packaging Revenue by Application (2021-2032)
- 7.2.1 Global Biobased Pharmaceutical Packaging Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Biobased Pharmaceutical Packaging Revenue Market Share by Application (2021-2032)
- 7.3 Global Biobased Pharmaceutical Packaging Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Biobased Pharmaceutical Packaging Value Chain Analysis
- 8.1.1 Biobased Pharmaceutical Packaging Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Biobased Pharmaceutical Packaging Production Mode & Process
- 8.2 Biobased Pharmaceutical Packaging Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Biobased Pharmaceutical Packaging Distributors
- 8.2.3 Biobased Pharmaceutical Packaging Customers
9 Global Biobased Pharmaceutical Packaging Analyzing Market Dynamics
- 9.1 Biobased Pharmaceutical Packaging Industry Trends
- 9.2 Biobased Pharmaceutical Packaging Industry Drivers
- 9.3 Biobased Pharmaceutical Packaging Industry Opportunities and Challenges
- 9.4 Biobased Pharmaceutical Packaging Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst